Adam L. Halberstadt, Ph.D.
Affiliations: | 2006 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Neuranatomy, Vestibular NeurophysiologyGoogle:
"Adam Halberstadt"Mean distance: 15.71 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Carey D. Balaban | grad student | 2001-2006 | University of Pittsburgh | |
| (Anatomical characterization of serotonergic and nonserotonergic projections from the dorsal raphe nucleus to the vestibular nuclei.) | ||||
| Mark Geyer | post-doc | 2007-2012 | UCSD | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Klein AK, Chatha M, Laskowski LJ, et al. (2021) Investigation of the Structure-Activity Relationships of Psilocybin Analogues. Acs Pharmacology & Translational Science. 4: 533-542 |
| Amodeo DA, Hassan O, Klein L, et al. (2020) Acute serotonin 2A receptor activation impairs behavioral flexibility in mice. Behavioural Brain Research. 395: 112861 |
| Brandt SD, Kavanagh PV, Westphal F, et al. (2020) Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ). Drug Testing and Analysis |
| Brandt SD, Carlino L, Kavanagh PV, et al. (2020) Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants. Drug Testing and Analysis |
| Jensen AA, Halberstadt AL, Märcher-Rørsted E, et al. (2020) The selective 5-HT receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [H]25CN-NBOH. Biochemical Pharmacology. 177: 113979 |
| Marcher-Rørsted E, Halberstadt AL, Klein AK, et al. (2020) Investigation of the 2,5-dimethoxy motif in phenethylamine Serotonin 2A receptor agonists. Acs Chemical Neuroscience |
| Brandt SD, Kavanagh PV, Westphal F, et al. (2020) Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). Drug Testing and Analysis |
| Halberstadt AL, Chatha M, Klein AK, et al. (2020) Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology. 107933 |
| Halberstadt AL, Chatha M, Klein AK, et al. (2019) Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD). Neuropharmacology. 107856 |
| Wallach J, Colestock T, Agramunt J, et al. (2019) Pharmacological characterizations of the legal high fluorolintane and isomers. European Journal of Pharmacology. 172427 |